Literature DB >> 3688300

Chondrosarcoma in the young. A clinicopathologic analysis of 79 patients younger than 21 years of age.

A G Huvos1, R C Marcove.   

Abstract

We have studied 79 patients with chondrosarcoma who were younger than 21 years of age; this number represents 16% of all patients with chondrosarcoma diagnosed and treated in this hospital during half a century. The appendicular skeleton (53%), the humerus (13%), and the femur (23%) were most frequently affected. The pelvic bones were also common locations (20%). Pain, the presence of a mass, and tenderness were the most common presenting complaints. Two-thirds of the sarcomas were central lesions; the rest were mostly of the peripheral type. In 22 patients (28%), the chondrosarcomas were secondary to pre-existing benign solitary or multiple cartilaginous lesions. Histologically, the chondrosarcomas were subdivided into conventional, myxoid, "mesenchymal," and spindle cell (dedifferentiated) variants. Microscopically, the chondrosarcomas were graded according to their increasing grade of malignancy (grade I: 24 patients; grade II: 23 patients; grade III: 32 patients). Detailed survival analysis was performed and survival comparisons were made between the various age groups, the time of treatment, the sex of the patients, various skeletal sites, and the histologic grade of malignancy of the chondrosarcoma. It appears that chondrosarcoma affecting younger individuals is, in general, a more ominous tumor as compared with adults; i.e., relatively more high-grade chondrosarcomas affect young people than adults. Another notable difference was the dissimilarity in the skeletal distribution pattern of the malignant cartilage lesions between adults and the young.

Entities:  

Mesh:

Year:  1987        PMID: 3688300     DOI: 10.1097/00000478-198712000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

1.  Case report 641: Chondroblastoma-like osteosarcoma.

Authors:  F Schajowicz; J D de Próspero; E Cosentino
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

2.  Secondary chondrosarcoma of the pelvis arising from a solitary exostosis in an 11-year-old patient: a case report with 5-year follow-up.

Authors:  Lukas M Nystrom; Barry R DeYoung; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2013

3.  Chondrosarcoma of the head and neck.

Authors:  Sei Young Lee; Young Chang Lim; Mee Hyun Song; Jae Yeon Seok; Won Sang Lee; Eun Chang Choi
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

4.  An incidental finding in a young woman (2006: 2b).

Authors:  M Paz Lorente; Carmen De Arriba; Javier Sáenz; Edurne Arteche; Khalil Abu-Shams; Raquel Beloqui
Journal:  Eur Radiol       Date:  2006-03-03       Impact factor: 5.315

5.  Case report 559: Chondrosarcoma of proximal humeral epiphysis.

Authors:  C L Young; F H Sim; K K Unni; R A McLeod
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

6.  Low-grade chondrosarcoma in a 12-year-old boy.

Authors:  T M Haygood; L Teot; W G Ward; A Allen; J U Monu
Journal:  Skeletal Radiol       Date:  1995-08       Impact factor: 2.199

7.  Cervical chondrosarcoma- rare malignancy: a case report.

Authors:  Shuaib Merchant; S M Azeem Mohiyuddin; Satish Rudrappa; R P Deo; Sagayaraj A; Lakshmi R Menon
Journal:  Indian J Surg Oncol       Date:  2014-09-14

8.  Malignant progression in two children with multiple osteochondromas.

Authors:  Gregory A Schmale; Douglas S Hawkins; Joe Rutledge; Ernest U Conrad
Journal:  Sarcoma       Date:  2010-05-09

Review 9.  Rare malignant mid-femoral tumours in the first decade of life. Report of three cases with short literature review.

Authors:  K Kozlowski; M Bellemore; F W Marsden; P Bale; A Kan
Journal:  Pediatr Radiol       Date:  1992

10.  Spinal chondrosarcoma: a review.

Authors:  Pavlos Katonis; Kalliopi Alpantaki; Konstantinos Michail; Stratos Lianoudakis; Zaharias Christoforakis; George Tzanakakis; Apostolos Karantanas
Journal:  Sarcoma       Date:  2011-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.